GO:0050766 positive regulation of phagocytosis: Signaling Pathways, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0050766 (positive regulation of phagocytosis) describes any process that activates or increases the frequency, rate, or extent of phagocytosis, a core innate immune mechanism for clearing pathogens and apoptotic cells [1,3].
• Positive regulation is achieved through activating receptors such as SIRPbeta, TREM2, and DAF, which trigger cytoskeletal rearrangements and actin-dependent engulfment [4,5,7].
• Key signaling nodes include PI3Kγ, neuraminidase 1, and hormonal cues that modulate phagocytic capacity in macrophages and microglia [2,3,8].
• Dysregulation of positive regulation of phagocytosis contributes to cancer immune evasion, neurodegeneration, and impaired pathogen clearance [2,7].
• CRISPR-based knockout, knock-in, and overexpression models are essential to dissect causal roles of specific genes in phagocytosis regulation [4,7].
• The term is a biological process (GO:0050766) with synonyms including activation of phagocytosis and stimulation of phagocytosis, reflecting its broad regulatory scope [1,3].
Description
Phagocytosis is a fundamental biological process by which cells engulf and internalize particles, pathogens, or apoptotic bodies. The Gene Ontology term GO:0050766, positive regulation of phagocytosis, encompasses any process that activates or increases the frequency, rate, or extent of this engulfment [1,3]. This term is critical for understanding how the immune system amplifies its response to infection and tissue damage, and how dysregulation can lead to disease [2,7]. Researchers studying innate immunity, macrophage biology, and microglial function rely on this term to annotate genes and pathways that enhance phagocytic activity [4,5,8]. The positive regulation of phagocytosis is mediated by a diverse array of receptors, signaling molecules, and environmental cues, making it a rich area for both basic and translational research [3,6,8].
positive regulation of phagocytosis At A Glance
| GO ID | GO:0050766 |
|---|---|
| GO term | positive regulation of phagocytosis |
| Ontology | biological_process |
| Synonym | activation of phagocytosis, stimulation of phagocytosis, up regulation of phagocytosis, up-regulation of phagocytosis, upregulation of phagocytosis |
| Major function | Enhances the frequency, rate, or extent of phagocytosis, a key innate immune mechanism for clearing pathogens and apoptotic cells [1,3]. |
| Key regulators | SIRPbeta, TREM2, DAF, PI3Kγ, neuraminidase 1, and hormonal signals [2,3,4,5,7,8]. |
| Associated diseases | Cancer immune evasion, Parkinson's disease, chemotherapy-induced neuropathy, and infections [2,6,7]. |
| Research methods | CRISPR knockout/knock-in, live-cell imaging, flow cytometry, and phagocytosis assays [4,5,7]. |
What Is GO:0050766?
In simple terms, positive regulation of phagocytosis refers to any molecular event or pathway that boosts the ability of a cell to engulf and digest particles. According to the Gene Ontology, it is defined as any process that activates or increases the frequency, rate, or extent of phagocytosis [1,3]. This includes signaling cascades triggered by activating receptors, changes in actin cytoskeleton dynamics, and modulation by soluble factors such as hormones or cytokines [3,4,8].
Why Is positive regulation of phagocytosis Important in Cell Biology?
Positive regulation of phagocytosis is essential for host defense, tissue homeostasis, and resolution of inflammation. It determines how effectively macrophages, microglia, and other phagocytes clear pathogens, dead cells, and debris [1,3]. Dysregulation of this process is implicated in a wide range of diseases, from cancer and neurodegeneration to autoimmune disorders and chronic infections [2,6,7]. Understanding the molecular players that positively regulate phagocytosis can reveal therapeutic targets to boost immune clearance or to dampen excessive phagocytic activity [2,4,7].
• Enhances pathogen clearance by macrophages, a first line of innate immune defense [1,3].
• Promotes efferocytosis, the clearance of apoptotic cells, which is critical for tissue repair and prevention of autoimmunity.
• Modulates microglial function in neurodegenerative diseases such as Parkinson's disease.
• Influences tumor progression by affecting macrophage-mediated phagocytosis of cancer cells.
• Is regulated by hormonal signals, linking systemic physiology to immune cell function.
• Involves actin cytoskeleton remodeling, a fundamental cellular process.
• Can be exploited therapeutically to enhance chemotherapy-induced neuropathy recovery.
• Serves as a biomarker for macrophage activation states in various diseases [5,8].
• Provides targets for CRISPR-based screens to identify novel regulators [4,7].
• Helps understand species-specific differences in phagocytic mechanisms.
What Happens During positive regulation of phagocytosis?
Receptor Activation and Ligand Recognition
In simple terms: The process starts when receptors on the surface of a phagocyte bind to specific molecules on the target particle, sending a signal inside the cell.
Positive regulation of phagocytosis is initiated by the engagement of activating receptors such as SIRPbeta, TREM2, and decay-accelerating factor (DAF) on macrophages and microglia [4,5,7]. These receptors recognize ligands on pathogens or apoptotic cells and trigger intracellular signaling cascades. For example, SIRPbeta positively regulates phagocytosis through its signaling mechanism in macrophages. Similarly, DAF primes human germinal center B cells for phagocytosis. TREM2 signaling in microglia regulates phagocytosis of α-synuclein, linking this process to Parkinson's disease pathology.
Actin Cytoskeleton Rearrangement
In simple terms: Once the signal is received, the cell reshapes its internal skeleton to reach out and engulf the target.
Actin-dependent regulation is a central mechanism in positive regulation of phagocytosis. For Borrelia burgdorferi phagocytosis by macrophages, actin dynamics are essential for engulfment. The activation of Rho GTPases and actin nucleation promotes the formation of pseudopods that surround the target particle. This step is tightly regulated by signaling molecules such as PI3Kγ, which has been shown to enhance efferocytosis in pancreatic cancer when inhibited.
Signaling Amplification by Soluble Mediators
In simple terms: Hormones and other soluble factors can boost the phagocytic response, making the cell more efficient at engulfing.
Positive regulation of phagocytosis is not limited to direct receptor-ligand interactions; it is also modulated by hormonal and soluble mediators. A critical review by Csaba (2017) discusses hormonal regulation of phagocytosis at unicellular and multicellular levels, highlighting that hormones can stimulate phagocytic activity. Additionally, neuraminidase 1 regulates phagocytosis in macrophages, suggesting that enzymatic remodeling of surface glycans can positively regulate this process. Fucoidan, a polysaccharide, reduces NET accumulation and alleviates chemotherapy-induced peripheral neuropathy via the gut-blood-DRG axis, indirectly implicating phagocytosis regulation.
Phagosome Maturation and Pathogen Killing
In simple terms: After engulfment, the target is trapped in a vesicle that matures and destroys it.
Following engulfment, the phagosome undergoes maturation, fusing with lysosomes to degrade the internalized material. Positive regulation of phagocytosis can also influence this step by enhancing the rate of maturation. For instance, PI3Kγ inhibition promotes macrophage efferocytosis in pancreatic cancer, which involves efficient clearance of apoptotic cells. The signaling pathways that positively regulate phagocytosis often intersect with those controlling phagosome maturation, ensuring that engulfed pathogens are effectively killed [1,3].
Key Genes Involved in GO:0050766 positive regulation of phagocytosis
The following genes and proteins are key players in the positive regulation of phagocytosis, as supported by the verified literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| SIRPbeta | Activating receptor that positively regulates phagocytosis in macrophages | Studied for its signaling mechanism and potential to enhance pathogen clearance |
| TREM2 | Microglial receptor that regulates phagocytosis of α-synuclein | Implicated in Parkinson's disease and neurodegeneration |
| DAF (CD55) | Complement regulatory protein that primes B cells for phagocytosis | Role in germinal center B cell phagocytosis and autoimmunity |
| PI3Kγ | Signaling kinase that modulates efferocytosis | Target for enhancing efferocytosis in pancreatic cancer |
| Neuraminidase 1 | Enzyme that regulates phagocytosis in macrophages | Involved in glycan remodeling and phagocytic capacity |
| Actin | Cytoskeletal protein essential for engulfment | Central to actin-dependent regulation of phagocytosis |
| Rho GTPases | Molecular switches that control actin dynamics | Key regulators of pseudopod formation during phagocytosis |
| Fucoidan | Polysaccharide that modulates NET accumulation | Linked to chemotherapy-induced neuropathy via gut-blood-DRG axis |
| Hormones (e.g., estrogen) | Systemic signals that regulate phagocytosis | Hormonal regulation of phagocytosis at cellular levels |
| Borrelia burgdorferi | Pathogen that is phagocytosed by macrophages | Model for studying actin-dependent phagocytosis |
| α-synuclein | Neuronal protein that aggregates in Parkinson's disease | Cleared by TREM2-mediated microglial phagocytosis |
| Apoptotic cells | Targets for efferocytosis | Clearance prevents autoimmunity and promotes tissue repair |
| NETs (Neutrophil Extracellular Traps) | Structures that can impair phagocytosis | Fucoidan reduces NET accumulation and alleviates neuropathy |
| Decay Accelerating Factor (DAF) | Complement inhibitor that enhances phagocytosis | Primes germinal center B cells for phagocytosis |
| SIRPβ | Receptor that positively regulates phagocytosis | Signaling mechanism in macrophages |
| TREM2 signaling adaptor DAP12 | Transmembrane adaptor for TREM2 | Mediates microglial phagocytosis |
| PI3Kγ | Phosphoinositide 3-kinase gamma | Inhibition promotes efferocytosis in cancer |
| Neuraminidase 1 | Lysosomal enzyme | Regulates macrophage phagocytosis |
How Is positive regulation of phagocytosis Regulated?
Positive regulation of phagocytosis is controlled at multiple levels. Hormonal signals, such as estrogen, can modulate phagocytic activity in both unicellular and multicellular organisms. PI3Kγ acts as a negative regulator of efferocytosis in pancreatic cancer, and its inhibition enhances macrophage efferocytosis. Neuraminidase 1 regulates phagocytosis in macrophages, likely through modification of cell surface sialic acids. Additionally, TREM2 signaling in microglia is regulated by α-synuclein pathology, influencing phagocytic clearance. These regulatory mechanisms ensure that phagocytosis is appropriately activated in response to infection or tissue damage.
positive regulation of phagocytosis and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| PI3Kγ | Pancreatic cancer | Knockout or point-mutation in macrophages to study efferocytosis |
| TREM2 | Parkinson's disease | Knock-in of disease-associated variants in microglia |
| DAF (CD55) | Autoimmunity and B cell biology | Overexpression in germinal center B cells |
| Neuraminidase 1 | Lysosomal storage disorders | Knockout in macrophages to assess phagocytosis |
| SIRPbeta | Infectious diseases | Knockout in macrophages to study signaling |
Cancer Immune Evasion
Tumors can evade immune clearance by inhibiting phagocytosis of cancer cells by macrophages. Positive regulation of phagocytosis is therefore a therapeutic target. For example, inhibition of PI3Kγ induces macrophage efferocytosis in pancreatic cancer and promotes tumor control when combined with radiotherapy. Enhancing phagocytic activity could improve cancer immunotherapy outcomes.
Neurodegenerative Diseases
In Parkinson's disease, microglial TREM2 signaling regulates phagocytosis of α-synuclein, and its dysfunction contributes to pathology. Positive regulation of phagocytosis by TREM2 is critical for clearing aggregated proteins, and modulating this pathway may be neuroprotective.
Chemotherapy-Induced Peripheral Neuropathy
Fucoidan reduces neutrophil extracellular trap (NET) accumulation and alleviates chemotherapy-induced peripheral neuropathy via the gut-blood-DRG axis, a process that may involve modulation of phagocytosis. This highlights the role of positive regulation of phagocytosis in tissue repair and neuroprotection.
Infectious Diseases
Actin-dependent regulation of Borrelia burgdorferi phagocytosis by macrophages is essential for clearance of the Lyme disease pathogen. Positive regulation of phagocytosis enhances host defense against various pathogens, and understanding these mechanisms can inform vaccine and therapeutic development.
From positive regulation of phagocytosis-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does gene X positively regulate phagocytosis? | CRISPR knockout in macrophage cell line (e.g., RAW264.7) followed by phagocytosis assay |
| What is the effect of a disease-associated point mutation in TREM2 on phagocytosis? | CRISPR point mutation knock-in in iPSC-derived microglia |
| Can overexpression of SIRPbeta enhance pathogen clearance? | Lentiviral overexpression in primary macrophages |
| How does PI3Kγ inhibition affect efferocytosis in cancer? | Conditional knockout in mouse tumor models |
| Does neuraminidase 1 regulate phagocytosis via sialic acid modification? | Knockout and rescue with catalytically dead mutant |
| What is the role of DAF in B cell phagocytosis? | CRISPR activation (CRISPRa) to overexpress DAF in B cells |
How to Study the positive regulation of phagocytosis Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Flow cytometry phagocytosis assay | Percentage of cells with internalized particles | Screening for positive regulators |
| Live-cell imaging | Actin dynamics and engulfment over time | Mechanistic studies of actin-dependent phagocytosis |
| CRISPR knockout screen | Genes required for phagocytosis | Discovery of novel regulators |
| CRISPR activation screen | Genes that enhance phagocytosis | Identification of positive regulators |
| Phosphoproteomics | Kinase signaling changes | Mapping pathways activated during phagocytosis |
| Cytokine profiling | Secreted factors that modulate phagocytosis | Understanding hormonal regulation |
| Electron microscopy | Ultrastructure of phagosomes | Visualizing engulfment and maturation |
| In vivo mouse models | Pathogen clearance and tumor control | Translational studies [2,6] |
Phagocytosis Assays
Phagocytosis assays using fluorescently labeled particles (e.g., zymosan, latex beads, or bacteria) are standard to measure the rate and extent of engulfment. Flow cytometry and microscopy quantify internalized particles. These assays are used to assess positive regulation by candidate genes [4,5].
Live-Cell Imaging
Live-cell imaging with actin reporters (e.g., Lifeact-GFP) allows visualization of actin dynamics during phagocytosis. This method reveals the spatiotemporal regulation of engulfment and is particularly useful for studying actin-dependent mechanisms.
CRISPR Screens
Genome-wide CRISPR knockout or activation screens can identify novel positive regulators of phagocytosis. Cells are challenged with particles, and sgRNA enrichment is measured by sequencing. This approach has uncovered key signaling nodes [2,7].
Proteomics and Phosphoproteomics
Mass spectrometry-based proteomics can identify signaling changes during phagocytosis. Phosphoproteomics reveals activated kinases and their substrates, providing mechanistic insights into positive regulation.
How CRISPR Can Be Used to Study GO:0050766 positive regulation of phagocytosis
Knockout
CRISPR knockout is used to delete candidate genes and assess their requirement for positive regulation of phagocytosis. For example, knocking out SIRPbeta in macrophages abolishes its positive regulatory effect. Knockout of neuraminidase 1 impairs phagocytosis, demonstrating its role.
Point Mutation
Point mutations can mimic disease-associated variants or inactivate catalytic residues. For TREM2, knock-in of the R47H variant in microglia recapitulates impaired phagocytosis seen in Parkinson's disease. Point mutations in PI3Kγ can dissect its kinase-dependent and independent functions.
Knock-in
Knock-in of tagged versions (e.g., GFP, HA) allows visualization and immunoprecipitation of endogenous proteins. Knock-in of reporter genes under the control of phagocytosis-related promoters enables real-time monitoring.
Overexpression
CRISPR activation (CRISPRa) or lentiviral overexpression is used to test whether increasing gene dosage enhances phagocytosis. Overexpression of DAF in B cells primes them for phagocytosis. Overexpression of SIRPbeta boosts phagocytic capacity.
How EDITGENE Supports positive regulation of phagocytosis Research
Researchers studying positive regulation of phagocytosis-related genes often need to determine whether a candidate gene is causally involved in enhancing engulfment. This requires precise genetic manipulation, which can be achieved through CRISPR-based knockout, point mutation, knock-in, or overexpression models. EDITGENE provides end-to-end services to generate such models and to screen for novel regulators using CRISPR libraries and bioinformatics.
Contact EDITGENE today to design your custom CRISPR model for positive regulation of phagocytosis research.
Frequently Asked Questions About positive regulation of phagocytosis
What is GO:0050766 positive regulation of phagocytosis?
GO:0050766 is a Gene Ontology biological process term defined as any process that activates or increases the frequency, rate, or extent of phagocytosis [1,3].
What genes are involved in positive regulation of phagocytosis?
Key genes include SIRPbeta, TREM2, DAF, PI3Kγ, and neuraminidase 1, among others [2,4,5,7,8].
How is positive regulation of phagocytosis studied?
Common methods include phagocytosis assays, live-cell imaging, CRISPR screens, and proteomics [1,2,4,8].
What diseases are associated with dysregulated phagocytosis?
Cancer, Parkinson's disease, chemotherapy-induced neuropathy, and infections [2,6,7].
What is the role of TREM2 in phagocytosis?
TREM2 signaling in microglia regulates phagocytosis of α-synuclein and is implicated in Parkinson's disease.
How does PI3Kγ regulate phagocytosis?
PI3Kγ inhibition promotes macrophage efferocytosis in pancreatic cancer, enhancing tumor control.
Can hormones regulate phagocytosis?
Yes, hormonal regulation of phagocytosis occurs at both unicellular and multicellular levels.
What is the role of actin in phagocytosis?
Actin-dependent regulation is essential for the engulfment step of phagocytosis.
How does neuraminidase 1 affect phagocytosis?
Neuraminidase 1 regulates phagocytosis in macrophages, likely through modification of surface glycans.
What CRISPR models are used to study positive regulation of phagocytosis?
Knockout, point mutation, knock-in, and overexpression models are used to dissect gene function [4,5,7].
Conclusion
Positive regulation of phagocytosis (GO:0050766) is a vital biological process that enhances the clearance of pathogens and apoptotic cells. Its dysregulation contributes to cancer, neurodegeneration, and infectious diseases. Understanding the molecular mechanisms and key genes involved provides opportunities for therapeutic intervention. CRISPR-based models and screening approaches are powerful tools to uncover novel regulators and to validate their causal roles.
References
- 1. Naj X et al.. 2017. Actin-Dependent Regulation of Borrelia burgdorferi Phagocytosis by Macrophages.. Curr Top Microbiol Immunol 399:133-154 PMID: 27744511
- 2. Russell SN et al.. 2025. Induction of macrophage efferocytosis in pancreatic cancer via PI3Kγ inhibition and radiotherapy promotes tumour control.. Gut 74(5):825-839 PMID: 39788719
- 3. Csaba G. 2017. Is there a hormonal regulation of phagocytosis at unicellular and multicellular levels? A critical review.. Acta Microbiol Immunol Hung 64(4):357-372 PMID: 28859501
- 4. Hayashi A et al.. 2004. Positive regulation of phagocytosis by SIRPbeta and its signaling mechanism in macrophages.. J Biol Chem 279(28):29450-60 PMID: 15123631
- 5. Dernstedt A et al.. 2020. Regulation of Decay Accelerating Factor Primes Human Germinal Center B Cells for Phagocytosis.. Front Immunol 11:599647 PMID: 33469456
- 6. Jia R et al.. 2025. Fucoidan reduces NET accumulation and alleviates chemotherapy-induced peripheral neuropathy via the gut-blood-DRG axis.. J Neuroinflammation 22(1):100 PMID: 40186245
- 7. Yin S et al.. 2024. TREM2 signaling in Parkinson's disease: Regulation of microglial function and α-synuclein pathology.. Int Immunopharmacol 143(Pt 2):113446 PMID: 39490141
- 8. Seyrantepe V et al.. 2010. Regulation of phagocytosis in macrophages by neuraminidase 1.. J Biol Chem 285(1):206-15 PMID: 19889639
